MMedication Read More What are the benefits and risks of GLP-1 drugs beyond weight loss?August 22, 2026 BATON ROUGE, La. (WAFB/Gray News) — Doctors have used GLP-1 drugs for weight loss for about five years,…
MMedication Read More GLP-1 Drugs Have Been Linked to More Than 200 Reported Deaths in the UK AloneAugust 14, 2026 Credit: Pexels The GLP-1 rush has taken the world by storm. Ozempic, Wegovy and Mounjaro have become household…
HHealth Read More More than 150 deaths reported after weight loss drug useAugust 6, 2026 More than 150 deaths have been linked to weight loss jabs, according to figures published by the Medicines…
HHealth Read More MHRA Warns of Botulism Risk After Botulinum Toxin UseJuly 17, 2026 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an updated safety warning for all botulinum toxin…
MMedication Read More Statins Rarely Cause Severe Muscle Problems, Researchers SayJuly 5, 2026 New research reports that serious muscular disorders are rare for people who take statins to help lower cholesterol…
MMedication Read More SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic DiseaseJune 27, 2026 SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
MMedication Read More Microdosing GLP-1s like Ozempic: the trend a doctor wants you to understand firstJune 22, 2026 Please note: This article is based on an exclusive interview with Oluwatosin Ajao, MD, a triple board-certified physician…
MMedication Read More Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’June 16, 2026 Despite the common perception that GLP-1 use is an easy way out for weight loss, the reality is…
MMedication Read More The next goal for weight loss drugs? Fewer injectionsJune 9, 2026 For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
NNutrition Read More Supplement Recalled Over ‘Fatal Physiological’ RisksMay 31, 2026 A popular dietary supplement is being pulled from the market after the U.S. Food and Drug Administration (FDA)…
MMedication Read More Ozempic users in Australia: Shocking number revealedMay 24, 2026 A wave of prescription weight-loss medications has swept across Australia, reshaping how doctors treat obesity and forcing regulators…
HHealthcare Read More Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facilityMay 7, 2026 “This expansion reflects the strength of a long-standing partnership between Lilly and the state of Indiana – one…